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Abstract
Oligodendrocytes, the myelin-forming glial cells of the central nervous system, maintain long-
term axonal integrity1–3. However, the underlying support mechanisms are not understood4. Here
we identify ametabolic component of axon–glia interactions by generating conditional Cox10
(protoheme IX farnesyltransferase) mutant mice, in which oligodendrocytes and Schwann cells
fail to assemble stable mitochondrial cytochrome c oxidase (COX, also known as mitochondrial
complex IV). In the peripheral nervous system, Cox10 conditional mutants exhibit severe
neuropathy with dysmyelination, abnormal Remak bundles, muscle atrophy and paralysis.
Notably, perturbing mitochondrial respiration did not cause glial cell death. In the adult central
nervous system, we found no signs of demyelination, axonal degeneration or secondary
inflammation. Unlike cultured oligodendrocytes, which are sensitive to COX inhibitors5, post-
myelination oligodendrocytes survive well in the absence of COX activity. More importantly, by
in vivo magnetic resonance spectroscopy, brain lactate concentrations inmutants were increased
compared with controls, but were detectable only in mice exposed to volatile anaesthetics. This
indicates that aerobic glycolysis products derived from oligodendrocytes are rapidly metabolized
within white matter tracts. Becausemyelinated axons can use lactate when energy-deprived6, our
findings suggest a model in which axon– glia metabolic coupling serves a physiological function.
†Present addresses: Center for Neuroregeneration, University of Edinburgh, 49 Little France Crescent, Edinburgh EH16 4SB,UK
(D.M.); Department of Molecular Physiology, Institute of Physiology, University of Saarland, D-66421 Homburg, Germany (A.S.S.);
Department of Neurosurgery, Charite - University Medicine Berlin, Chariteplatz 1, D-10117 Berlin, Germany (B.G.B.); Department
of Diagnostic Radiology, Am Botanischen Garten 14, University of Kiel, D-24118 Kiel, Germany.
Contributions U.F., L.M.S., C.M.K. and I.D.T. performed mouse breeding experiments, histology and light microscopy; D.Ma.
carried out immunohistochemistry; S.B .performed magnetic resonance imaging and spectroscopy; A.S.S. and J.E. carried out ex vivo
experiments; B.G.B. and M.W.S. performed electrophysiology; W.M. performed electron microscopy; F.D. and C.T.M. provided
floxed mice; D.Mi. and U.S. provided Cre-transgenic lines. B.H., J.F. and S.G. supervised parts of the work or contributed essential
ideas. K.-A.N. designed experiments, analysed data and wrote the manuscript.
Europe PMC Funders Group
Author Manuscript
Nature. Author manuscript; available in PMC 2013 April 02.
Published in final edited form as:
Nature. ; 485(7399): 517–521. doi:10.1038/nature11007.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
The nuclear Cox10 gene encodes a haem A farnesyl transferase, essential for the assembly
of COX, the terminal complex of the electron transport chain in mitochondria7, 8. In COX10
mutants, COX is unstable and rapidly degraded. Cox10flox/flox mice have been used to
generate models of severe mitochondrial disease in muscle, brain and liver7, 8, 9, 10. We
crossed the Cox10flox/flox line7with Cnp1Cre/+ mice2 that express Cre recombinase in
Schwann cells and oligodendrocytes (with Cre expression beginning at the respective
precursor stages in these cells)11, 12. In the absence of functional COX, glial cells should fail
to fully metabolize glucose, and should generate ATP mostly by glycolysis and produce
lactate. Thus, demyelination and glial cell death would be key indicators for metabolic
demands of glial cells, toxic effects of lactic acidosis, and metabolic coupling between
neuronal and glial compartments in myelinated fibre tracts.
Crosses of Cox10flox/+*Cnp1Cre/+ and Cox10flox/flox*Cnp1+/+ mice led to fewer mutant pups
(Cox10flox/flox*Cnp1Cre/+) than expected (11% compared with 25% expected, n = 466),
suggesting prenatal death of some mice, probably owing to the known Cnp1Cre/+ expression
in a subset of neural precursors (see later). We therefore generated other mutants by
selectively targeting Schwann cells (using Dhh-Cre mice) and mature oligodendrocytes
(using tamoxifen-inducible Plp1-CreERT2 mice), and found no evidence of embryonic
lethality. In the following, data are fromCnp1Cre/+*Cox10flox/flox mutants (and
Cnp1Cre/+*Cox10flox/+ controls), unless otherwise stated.
Quantitative polymerase chain reaction (qPCR) of genomic DNA from neural tissue (at
postnatal day (P) 21) confirmed the loss of exon 6 and thus a functional Cox10 gene (Fig.
1a, b). For the sciatic nerve we calculated that 67 ± 2% (mean ± s.e.m., n = 4) of all cells
were recombinant (assuming that both alleles recombine). Thus, most Schwann cells in
peripheral nerves were successfully targeted. In the optic nerve and cervical spinal cord, we
calculated that about 50% of cells were recombined at the Cox10 locus (Fig. 1b), the
estimated percentage of oligodendrocytes13.
Elimination of Cox10 is not immediately followed by the loss of respiration, but predicts the
rapid functional ‘ageing’ of mitochondria, as the mitochondrial half-life is about 3 weeks in
the brain14, 15. Thus, postnatal myelination by oligodendrocytes will involve intact
mitochondria (Fig. 1c). By contrast, recombination of Cox10 in proliferating Schwann cells
causes a more rapid ‘loss’ of intact mitochondria by dilution in the progeny (Fig. 1c, right).
Indeed, the absence of COX from many Schwann cells was obvious at P21 (Fig. 1d). For
comparison, immunostaining of axonal mitochondria was indistinguishable between mutants
and controls. We also noted occasional spinal motor neurons lacking COX (not shown), a
plausible contributor to embryonic lethality.
A severe neuropathy phenotype proved that gene targeting was efficient and disruptive for
mitochondrial function. Both Cnp1Cre/+*Cox10flox/flox and Dhh-Cre*Cox10flox/flox mice
exhibited a developmental defect, with reduced weight, tremors and hindlimb weakness,
although mutants appeared otherwise healthy and well groomed. The disease progressed to
hindlimb paralysis and muscle atrophy (Supplementary Fig. 1a), followed by forelimb
paralysis at about 9 months, when mutants had to be euthanized.
Already at P21 attempts to compare sciatic nerve conduction velocities between controls
(15.6 ± 0.7 m s−1; mean ± s.e.m.; n = 5) and mutant mice (n = 5) failed, indicating
conduction blocks (Fig. 2a). Only distal stimulation elicited a compound muscle action
potential in mutant mice, but with 50% reduced amplitude (Supplementary Fig. 1b),
indicating a combination of glial and axonal perturbations. The same functional blocks were
seen in Dhh-Cre*Cox10flox/flox mice (not shown), confirming the specificity for Schwann
cells.
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By morphology and TdT-mediated dUTP nick end labelling (TUNEL) staining, we found no
evidence for Schwann cell death as a possible cause of hypomyelination (not shown). In
fact, the number of cell nuclei was increased (Fig. 2b). Compared with controls, mutant
nerves were thinner (Fig. 2c), the absolute number of myelinated axons was reduced (Fig.
2d) and many medium-sized axons remained unmyelinated (Supplementary Fig. 1c, d).
However, neither large nor small axons were significantly altered in number (Supplementary
Fig. 2a), suggesting a primary dysmyelination at P21. By immunostaining for the activated
monocyte/macrophage marker MAC3, reactive macrophages were found to not yet be a
feature (not shown), confirming the developmental defect. At later stages, the number of
myelinated axons was reduced (Fig. 2d), and in 2-month-old mice fibre degeneration was
already associated with secondary inflammation (Supplementary Fig. 2b). Notably, even at 9
months there was no major loss of Schwann cells, with 193 ± 25 per sciatic nerve section in
mutants and 239 ± 17 in controls (mean ± s.e.m., n = 4).
Where myelin was present, g-ratio analysis (the ratio between the diameter of the inner axon
and the total outer diameter) showed a decrease in myelin thickness (0.589 ± 0.009 in
controls; 0.612 ± 0.012 in mutants; mean ± s.d., n = 3). By electron microscopy, many axons
that appeared correctly sorted remained unmyelinated, despite a calibre >1.0 μm (Fig. 2e–g).
Remak cells failed to engulf single axons with cellular processes (Fig. 2f). Thus, the axonal
sorting defect in mice lacking the transcription factor TFAM1 (ref. 16) is probably the
consequence of perturbed COX activity in Schwann cells.
Mitochondria were visibly enlarged in mutant Schwann cells (Fig. 2h, i), but not in
associated axons (Supplementary Fig. 2c), reflecting a loss of the proton gradient and a
failure of H+/K+antiporters17. Compacted myelin, when present, had a normal ultrastructure
and was stable (Fig. 2h, i).
An intriguing aspect of altered energy metabolism in peripheral nerves was the increase of
vascularization. Blood vessels covered a threefold larger area in cross-sections from mutant
nerves (Supplementary Fig. 3a–c). Hypervascularization was associated with upregulation of
Vegfamessenger RNA, but not of Hif1a or glucose transporters (Supplementary Fig. 3d),
and is possibly a response to enhanced glycolysis.
Myelinated tracts were normally developed in brains and spinal cords of mice at 2 months of
age (Supplementary Fig. 4), which is best explained by sufficient respiration of
oligodendroglial mitochondria during myelination (Fig. 1c). The fact that losing
mitochondrial function requires several weeks was confirmed by inactivating Cox10 in
postmitotic neurons (at P5–P10) usingCamKII-Cre mice. As previously shown10, these mice
die prematurely with severe neurodegeneration, visualized by neuroinflammation and loss of
hippocampal neurons at 4 months of age (Supplementary Fig. 5).
Surprisingly, even at 9 months of age when Cnp1Cre/+*Cox10flox/flox mice had to be killed
because of peripheral neuropathy, we detected no signs of white matter pathology,
demyelination or oligodendroglial pathology (Fig. 3a–f), although the absence of COX
activity from oligodendrocyte lineage cells was obvious by sequential COX and succinate
dehydrogenase (SDH, also known as mitochondrial complex II) histochemistry (Fig. 3g and
Supplementary Fig. 6). Mature oligodendrocytes (CC1+) instead showed an abnormal
(SDH+) mitochondrial expansion, but were COX− (Fig. 3h). To extend the observational
time window, we induced recombination by tamoxifen inPlp1-CreERT2*Cox10flox/flox 1-
month-old mice. Histological analysis at age 14 months (the latest time-point tested) also
failed to show any signs of demyelination or neurodegeneration (Supplementary Fig. 7a–c).
Furthermore, magnetic resonance imaging (MRI) showed that there was no difference in
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ventricular volume between mutants (8.1 ± 1.1 mm3 (mean ± s.d.)) and controls (8.4 ± 1.4
mm3) at 6–7 months of age (Supplementary Fig. 7d, e).
Theoretically, white matter integrity could be preserved when mutant oligodendrocytes are
replaced by newly generated oligodendrocytes that remyelinate. These cells might again
survive for several weeks after recombination of Cox10. We think this is unlikely for several
reasons. By electron microscopy and g-ratio analysis, central nervous system (CNS) myelin
thickness in adult mutants was in the normal range (Fig. 3c, d and Supplementary Fig. 8),
unlike remyelinated axons that are hypomyelinated18. Moreover, we failed to observe
apoptotic cells in the white matter tracts of adultCox10 mutants (Supplementary Fig. 9a),
and the administration of BrdU did not label more oligodendrocyte precursor cells in
mutants than in age-matched controls (Supplementary Fig. 9b). Furthermore, staining for
astrocytes, microglia and T cells (Supplementary Fig. 10) gave no indication of low-grade
inflammation, a very sensitive response to degenerative processes in white matter tracts. We
conclude that once myelination has occurred, reduced mitochondrial functions do not
perturb oligodendrocyte survival, myelin maintenance or axonal integrity.
We proposed that oligodendrocytes survive by enhanced glycolysis, and predicted to see in
vivo an increase in the brain lactate concentration using localized proton magnetic resonance
spectroscopy (MRS). As expected, Cox10 mutants showed a more strongly increased lactate
resonance (compared with controls) in both cortex and white matter. Notably, accumulated
brain lactate was detectable only under isoflurane anaesthesia (Fig. 4a). When quantified in
adult mutants (Fig. 4b), we determined >4 mM lactate in the cortex and >6 mM in the
corpus callosum (compared with <2 mM lactate in the cortex and <4 mM in the white matter
of wild-type mice). At the end of anaesthesia, these lactate concentrations fell within
minutes to very low levels (Fig. 4c). The latter finding is compatible with a model in which
oligodendroglial release of lactate — the necessary by-product of aerobic glycolysis — is
followed by its rapid use in other cellular compartments. It is demonstrated in vitro that glial
lactate is efficiently metabolized by myelinated axons (Supplementary Fig. 11). In vivo,
lactate levels never reached MRS detectability under physiological conditions, unless
challenged by isoflurane anaesthesia. Of note, the levels of N-acetylaspartate (a marker of
viable neurons and axons), choline-containing compounds (indicators of membrane
turnover) and myo-inositol (an osmolyte and glial membrane constituent) further support our
conclusion that neurodegeneration and abnormal oligodendrocyte turnover are not a feature
(Supplementary Fig. 12).
COX10-deficient cells in culture are practically respiration-deficient19. Because we
combined well-established lines of floxed mice and Cre transgenic tools, the reported
phenotype is probably caused by the loss of mitochondrial ATP generation. In the periphery,
the mitotic expansion of (mutant) Schwann cell precursors rapidly dilutes functional
mitochondria, and hypomyelination demonstrates that myelination is an energy-consuming
process. We also note that many patients with mitochondrial disorders have signs of
neuropathy with hypomyelination. By contrast, unperturbed CNS myelination is best
explained by sufficient residual function of mitochondria in mature oligodendrocytes after
recombination (Fig. 1c). We note that germline mutations of humanCOX10 and other COX
assembly factors, although ultimately lethal, have been associated with CNS dysmyelination
(leukodystrophy)8.
Most intriguing is the mild post-myelination CNS phenotype of adult Cox10 mutant mice, in
which oligodendrocytes maintain myelin and their ensheathed axons. That mature
oligodendrocytes apparently survive by aerobic glycolysis similar to tumour cells (known as
the Warburg effect) was unexpected. In fact, oligodendrocytes in vitro are sensitive to the
COX inhibitor azide5. However, these cells correspond to ‘pre-myelinating’
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oligodendrocytes in vivo, and it seems that metabolic properties of oligodendrocyte lineage
cells change during maturation. After myelination, oligodendrocytes may tolerate a partly
glycolytic metabolism that we have experimentally augmented in Cox10 mutants. We note
that mature wild-type oligodendrocytes have lower COX activity than oligodendrocyte
precursor cells (not shown), and that white matter has relatively high glycolytic activity20.
Also, in our control mice absolute lactate levels (as a surrogate marker for aerobic
glycolysis) were higher in white than grey matter (Fig. 4b).
Enhanced glycolysis in oligodendrocytes increases the production of pyruvate, lactate and
acetyl-coenzyme A (CoA), the latter promoting fatty acid synthesis during myelination.
Because energy-deprived myelinated axons can rapidly use pyruvate and lactate as an
alternative energy source6,21 (Supplementary Fig. 11), we suggest a model in which an
increased rate of oligodendroglial glycolysis can supply glycolysis products to support
axonal energy needs (Fig. 4d).
Our observation that lactate levels in mutant brains are visibly increased compared with
controls, but only under isoflurane anaesthesia, suggests that lactate is not cleared by
drainage, but is locally metabolized. Isoflurane anaesthesia does not decrease CNS blood
flow. The theoretical possibility that increased lactate peaks are caused by mutant
oligodendrocytes that fail to metabolize neuronal lactate seems remote (note the similar
lactate increases in grey matter, where neurons are associated with respiration-competent
astrocytes22). Increased lactate concentrations probably originate from Cox10 mutant
oligodendrocytes that rely on increased glycolysis for survival. Even under normal
conditions, lactate exported from oligodendrocytes would be rapidly metabolized and
therefore not be detected by MRS.
By in situ hybridization23 and immunoelectron microscopy24, the monocarboxylate
transporter MCT1 (also known as SLC16A1) is expressed in white matter, and is even
present in myelin24, whereas MCT2 localizes to myelinated axons. This strongly suggests
that lactate generated in oligodendrocytes is released and reaches the axonal compartment
(Fig. 4d).
We assume that oligodendrocytes can oxidize glycolysis-derived NADH+ when
mitochondria are intact (using a NADH-glycerolphosphate shuttle that is oligodendrocyte-
specific25). Thus, normal oligodendrocytes may not even reduce pyruvate, which passes
equally well through MCT1 and MCT2. Such a model of oligodendrocytes, yielding
glycolysis products to axons when energy deprived4, does not contradict the presumed role
of lactate in the support of myelination during development24, that is, when the import of
metabolites is rate-limiting for lipid synthesis26, specifically for oligodendrocytes in
culture24.
Our model of axon–oligodendrocyte metabolic coupling is reminiscent of the astroglial
‘lactate shuttle’, which is thought to support the energy metabolism of glutamatergic
synapses in the cortex27, 28. For oligodendrocyte lineage cells, the inferred developmental
‘switch’ of metabolism even allows them to survive by aerobic glycolysis. The underlying
mechanisms deserve further attention, as they may be relevant for the survival of glioma
cells and the Warburg effect.
Methods
Animals
All animal experiments were carried out in compliance with animal policies of the State of
Lower Saxony, Germany. Animals were maintained on a C57/Bl6 genetic background.
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Cox10flox/flox mice7,Cnp1Cre/+ mice2, Dhh-Cre mice29, Plp1-CreERT2 mice30 and CamKII-
Cre31 mice were genotyped as described. Tamoxifen treatment30 was for 5 days, daily.
qPCR of genomic DNA
qPCR was performed using 10 ng of genomic DNA in a 12.5-μl assay using PowerSYBR
Green PCR Master Mix (Applied Biosystems) on an Applied Biosystems 7500 Fast Real
Time PCR system in triplicates. A standard curve was generated using genomic DNA from
Cox10flox/flox, Cox10flox/+ andCox10+/+ animals. The values were standardized to an
independent genomic marker. A 167-base-pair Cox10flox-specific fragment was obtained
with primers 5′-CGGGGATCAATTCGAGCTCGCC-3′ and 5′-
CACTGACGCAGCGCCAGCATCTT-3′. The percentage of Cox10 recombination was
calculated by assuming that recombination affects both floxed alleles in Cre-expressing
cells.
Quantitative PCR after reverse transcription
RNA was prepared in TRIzol (Invitrogen), followed by purification on a Qiagen RNeasy
column. Complementary DNA was synthesized from 0.5 μg of total RNA using
SuperscriptIII (Invitrogen) with random nonamer primers. qPCRs were run with
PowerSYBR Green PCR Master Mix (Applied Biosystems) on an Applied Biosystems 7500
Fast real-time PCR system in quadruplicates (outliers were removed). The following primers
were used: Gapdh, 5′-CAATGAATACGGCTACAGCAAC-3′ and 5′-
TTACTCCTTGGAGGCCATGT-3′; Glut-1 (also known as Slc2a1), 5′-
ATGGATCCCAGCAGCAAG-3′ and 5′-CCAGTGTTATAGCCGAACTGC-3′; Glut-3
(Slc2a3), 5′-CTGGACCTCCAACTTTCTGG-3′ and 5′-
GCAGCGAAGATGATAAAAACG-3′; Hif1a, 5′-CATGATGGCTCCCTTTTTCA-3′ and
5′-GTCACCTGGTTGCTGCAATA-3′; Vegfa, 5′-TTACTGCTGTACCTCCACC-3′ and
5′-ACAGGACGGCTTGAAGAT-3′; 18S RNA: 5′-
AAATCAGTTATGGTTCCTTTGGTC-3′ and 5′-
GCTCTAGAATTACCACAGTTATCCAA-3′.
Electrophysiology
Mice were anaesthetized with xylacin and ketamin intraperitoneally. Two recording
electrodes were inserted into the intrinsic foot muscle. Distal stimulation electrodes were
inserted at the ankle. The proximal stimulation electrodes were inserted at the sciatic notch.
Compound muscle action potentials (CMAPs) were recorded with a Jaeger-Toennies
Neuroscreen instrument. Nerve conduction velocities were calculated from the distance
between proximal and distal stimulation electrodes and the latency difference between the
CMAPs after successive proximal and distal stimulation. CMAP amplitudes were calculated
peak to peak.
Optic nerve recordings and oxygen glucose deprivation
Optic nerves from 2-month-old wild-type mice were gently removed and directly transferred
into an interface perfusion chamber (Haas Top, Harvard Apparatus) and superfused with
artificial cerebrospinal fluid (ACSF) containing: 124 mM NaCl, 3 mM KCl, 2 mM CaCl2, 2
mM MgSO4, 1.25 mM NaH2PO4, 23 mM NaHCO3 and 10 mM glucose. The perfusion
chamber was continuously aerated by a humidified mixture of 95% O2 and 5% CO2, and
experiments were performed at 37 °C. Custom-made suction electrodes, back-filled with
ACSF, were used for stimulation and recording. Compound action potentials (CAP) were
evoked every 30 s with a square-wave (50 μs, 0.8 mA) constant current stimulus pulse
(Stimulus Isolator 385, WPI). The recording electrode was connected to a Heka amplifier
(EPC9), and the signal was amplified 500 times, filtered at 30 kHz, and acquired at 20–30
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kHz. Before recording, optic nerves were equilibrated for at least 15 min in the chamber.
After 1-h baseline recordings, optic nerves were exposed to oxygen glucose deprivation
(OGD) for 1 h. OGD was induced by switching to glucose-free ACSF and a gas mixture
containing 95% N2 and 5% CO2 in the recording chamber. To ensure that no oxygen was
delivered by the superfusate, ACSF was always bubbled with 95% N2, 5% CO2. After OGD,
control ACSF and O2 were restored and CAPs were recorded for up to 2 h. To test the role
of pyruvate and lactate transporters on energetic recovery, 200 μM α-cyano-4-
hydroxycinnamic acid (Sigma Aldrich) was applied 20 min before recovery (for 40 min).
Optic nerve function was monitored over time, as the area under the CAP that was
normalized to baseline. Data are presented as mean ± s.e.m., with nindicating the number of
optic nerves used in these experiments.
Serial COX and SDH histochemistry
Cryostat sections (8-μm thickness) were air-dried for 30 min before the application of COX
medium (500 μM cytochrome c, 5 mM diaminobenzidine tetrahydrochloride and 20 mg
ml−1 catalase). After incubation in COX medium at 37 °C for 40 min, the sections were
washed three times using PBS and SDH medium (130 mM sodium succinate, 200 mM
phenazine methosulphate, 1 mM sodium azide, 1.5 mM nitroblue tetrazolium in 0.1 M
phosphate buffer, pH 7.0) was applied for 30 min at 37 °C.
Histology and immunohistochemistry
Animals were anaesthetized with avertin and perfused intracardially with 15 ml of HBSS,
followed by 50 ml of fixative (4% formalin in phosphate buffer). Dissected nerves were
postfixed overnight in fixative and embedded in paraffin. Gallyas’ silver impregnation was
performed as described2. Tissues for cryosections were dissected fresh, and snap-frozen or
immersion-fixed for 1 h in fixative, infiltrated with 20% sucrose in PBS, and frozen in
Shandon Cryomatrix. Antibodies used were mouse-anti-COX subunit-I (MitoSciences), rat-
anti-CD31 (BD Pharmingen), anti-GFAP (Chemicon), anti-MAC3 (BD Pharmingen) and
anti-CD3 (Serotec). Images were processed in Adobe Photoshop to equalize the contrast,
and the background around semithin sections was manually cleared.
For immunofluorescent labelling of OLIG2 after COX and SDH histochemistry, the sections
were fixed in cold 4% paraformaldehyde solution for 30 min and antigen retrieval was
performed using boiling EDTA buffer, pH 8, for 1 min. Sections were washed in TBS three
times for 5 min. Non-specific binding was blocked using 1% normal goat serum (Sigma)
diluted in TBS. Sections were then incubated with primary antibody (OLIG2, rabbit
immunoglobulin-G (IgG); Chemicon) overnight at 4 °C and detected using rhodamine-
conjugated anti-rabbit secondary antibody (Jackson Immunoresearch). Sections were
mounted using aqueous medium.
For double-labelling mitochondria in mature oligodendrocytes, we used COX-I (isotype
IgG2a) and SDH (IgG1) antibodies from Mitosciences, and CC1 (IgG2b) antibodies from
Calbiochem. Cryostat sections were air-dried for 30 min and fixed in cold 4%
paraformaldehyde for 30 min. Gentle antigen retrieval was performed by immersing the
section in boiling EDTA buffer, pH 7.4, for 30 s. After blocking in 1% normal goat serum,
primary antibodies (1:200 for SDH 70 kDa and COX-I, and 1:100 for CC1) were applied for
90 min at room temperature. Indirect detection was with directly conjugated Alexia Fluor
secondary antibodies (30 min at room temperature), and sections were mounted in Vector
shield.
The TUNEL assay was performed using DeadEndTM Colorimetric TUNEL System kit
following the manufacturer’s protocol (Promega). For labelling mitotic cells, BrdU (100 μg
Funfschilling et al. Page 7
Nature. Author manuscript; available in PMC 2013 April 02.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
g−1) was injected (intraperitoneally) at 4 months of age (for 4 weeks at 5 days a week).
Brains were embedded in paraffin and sections (5 μm) were stained with anti-BrdU
(Chemicon) and anti-OLIG2 antibodies (a gift from from C. Stiles).
Semithin sections and electron microscopy
Animals were anaesthetized with avertin and perfused intracardially with 15 ml of HBSS,
followed by 50 ml of fixative (2.5% glutaraldehyde, 4% paraformaldehyde in PBS).
Dissected nerves were postfixed overnight in fixative and embedded in Epon. Semithin
sections were stained with methylene blue and AzurII. Ultrathin sections were contrasted
with 1% uranyl acetate and lead citrate. Electron microscopic pictures were taken on a LEO
912AB electron microscope (Zeiss) with an on-axis 2048 × 2048 charge coupled device
camera (Proscan). All cell counts and tracings were done using ImageJ (http://
rsb.info.nih.gov/ij/). For semithin sections, entire cross-sections of sciatic nerves were
scored. Optic nerves were freshly isolated and cryofixed by high-pressure freezing and
freeze substituted. On electron microscopic pictures, all axons in three random fields (5,500
μm2total) per nerve were traced. The g-ratios were calculated from circular areas equal to
the measured area of the fibres.
MRI and MRS
MRI and MRS was performed as recently described32 on mutant and controls
(Cox10flox/+*Cnp1Cre/+) at 4–5 months (n = 6/6) and 6–7 months (n = 7/7). Mice were
initially anaesthetized with 5% isoflurane, subsequently intubated and kept under
anaesthesia with 1.75% isoflurane in ambient air. In four mice, further spectra were obtained
without anaesthesia. In these mice, pancuronium (15 mg kg−1) was administrated 15 min
before switching off the isoflurane supply to avoid movement artefacts. In vivo localized
proton MRS (STEAM, TR/TE/TM = 6,000/10/10 ms) in different regions of the brain
(cortex 3.9 × 0.7 × 3.2 mm3, corpus callosum 2.5 × 1.0 × 2.0 mm3, striatum 1.2 × 1.4 × 2.0
mm3, cerebrum 4 × 3 × 4 mm3) was performed at 9.4 T (Bruker Biospin GmbH). T2-
weighted MRI (2D FSE, TR/TE = 4,200/43 ms, 8 echoes, resolution 100 × 100 μm2, slice
thickness 300 μm) in axial and horizontal orientation served to ensure a proper position of
volumes-of-interest. These images were further used to measure the ventricular volume by
manual segmentation (Amira Software, Visage Imaging, Berlin, Germany). Metabolite
quantification involved spectral evaluation by LCModel33 and calibration with brain water
concentration. Metabolites with Cramer-Rao lower bounds above 20% were excluded from
further analyses unless noted otherwise.
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Figure 1. Genetic targeting of the mitochondrial COX complex in myelinating glial cells
a, Conditional mutagenesis of the floxed Cox10 gene, deleting exon 6 (not drawn to scale).
Arrows indicate the location of primers for genotyping (blue/red) and qPCR (red/red), the
latter amplifying only the floxed allele. b, Loss of the floxed Cox10 gene in myelinating
glial cells of different Cre-expressing mice (adult), confirmed by qPCR of genomic DNA.
Highest fraction of myelinating glia are found in sciatic nerve (SN), followed by optic nerve
(ON), cervical spinal cord (CSC) and total brain. Mean percentages ± s.d. are shown; n = 3–
5. c, Left panel, schematic time line showing that Cox10 genomic recombination in
immature oligodendrocytes of newborn Cnp1Cre/+ mice does not interfere with postnatal
myelination. Mutant oligodendrocytes myelinate (first 3 weeks), using pre-existing
mitochondria that will subsequently decline in respiratory function (marked ‘ageing’). Right
panel, for comparison, Cox10 recombination in proliferating Schwann cell precursors
perturbs mitochondrial function before myelination, as intact mitochondria are ‘lost’ by
dilution with mutant mitochondria. M, month. d, Right panels, myelinated axons and
Schwann cells in motor roots of control and mutant animals at P21. The left panel shows a
schematic representation. Cox10 mutant Schwann cells (but not axons) lose unstable COX,
as demonstrated by reduced immunostaining for the catalytic COX subunit I (brown) in
paraffin sections. Schwann cell nuclei (N) are counterstained in pale blue. Upward arrow,
COX staining of axonal mitochondria; downward arrow, COX in Schwann cells. Scale bar,
10 μm.
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Figure 2. Peripheral neuropathy caused by Cox10 mutant Schwann cells
a, Amplitudes of compound muscle action potentials were recorded in controls and mutant
mice at P21 after proximal or distal stimulation of sciatic nerves, but were barely detectable
in the mutants. b–d, The morphology of sciatic nerves was assessed in semithin sections,
and the number of Schwann cell nuclei was counted (b), the cross-sectional area of the nerve
with fascicles of axons and Schwann cells was determined (c), and the absolute number of
myelinated axons counted (d). This showed a progressive loss of axons at older age, but not
of Schwann cells. All data area mean ± s.d. Ctrl, control; mut, mutant. e–i, Electron
microscopy showed differences between mutant and control sciatic nerves. e, f, In Remak
bundles, C-fibre axons (C) are normally sorted by Schwann cell processes (e, arrow) but not
in mutants (f).g, Mutant Schwann cells that fail to myelinate survive well. Note numerous
unmyelinated medium-calibre axons (A) next to normally myelinated axons (N) and intact
Schwann cell nuclei (S). h, i, At higher magnification, myelin appeared morphologically
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normal, but mutant mitochondria (asterisk) were clearly enlarged. Scale bars, 500 nm (e, f,
h, i), 2 μm (g).
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Figure 3. Oligodendroglial survival, myelin preservation and white matter integrity
inCnp1Cre/+*Cox10flox/flox mice
a, b, By Gallyas’ silver impregnation of myelin at 9 months of age, the corpus callosum and
other white matter tracts appear normally developed and stable in mutant mice. c–f, Electron
microscopy of high-pressure frozen optic nerve shows intact myelination of CNS axons (c,
d), and healthy oligodendroglia nuclei (e, f). A, axon; N, nucleus; M, mitochondria. Scale
bars, 0.5 μm. g, Serial COX and SDH histochemistry. Left, in the normal appearing white
matter of 9-month-old Cnp1Cre/+*Cox10flox/flox mutants (corpus callosum), mitochondrial
COX activity yields a brown precipitate (axons and astrocytes, for example). By serial COX
and SDH histochemistry, only Cox10-mutant COX− cells are visibly stained for SDH (blue
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precipitate, white arrows). Middle, about half (48.2 ± 6.5%) of the OLIG2-positive
oligodendrocyte lineage cells in the mutant corpus callosum (red nuclei in overlay), that is,
mostly mature oligodendrocytes that express CNP1Cre, are lacking COX activity (blue).
Right, there are no COX− cells in the corpus callosum of age-matched controls. Scale bar,
20 μm. h, Left, when combining only COX histochemistry with a marker for mature cells
(CC1), mutant oligodendrocytes (corpus callosum; 9 months of age) appear white (arrows),
intermingled with COX+ neighbouring cells and compartments. Middle, mature
oligodendrocytes that are CC1+ (green) are filled with abnormally large numbers of SDH+
mitochondria (red), and appear in orange in the overlay. Note the near absence of SDH
signals from neighbouring cells and compartments. Right, in a separate overlay, the SDH+
mitochondria (red) are virtually devoid of COX immunostaining (green) in mutant
oligodendrocytes. Scale bar, 10 μm.
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Figure 4. Rapid use of lactate shown by proton MRS
a, Localized proton magnetic resonance spectra of the cortex (left) and corpus callosum
(right) fromCnp1Cre/+*Cox10flox/flox mutants and controls (6–7 months of age). Cr, total
creatine; Ins, myo-inositol; p.p.m., parts per million; NAA, N-acetylaspartate. Red arrows
denote lactate (Lac). b, Lactate levels in the cortex (left) and white matter (right) are
increased in mutant mice (grey bars) compared with controls (black bars) under isoflurane
anaesthesia. Data are mean ± s.e.m.; n = 6–7 per genotype. Note that under isoflurane
anaesthesia the control mice have higher lactate levels in white matter than in grey matter.
M, months. c, Increased brain lactate levels drop to undetectable levels in less than 60 min at
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the end of isoflurane anaesthesia. This suggests that lactate (produced by oligodendrocytes)
is rapidly metabolized by other cellular compartments in the white matter tracts of awake
mice. d, Hypothetical model of metabolic coupling between oligodendrocytes and
myelinated axons. Oligodendrocytes import glucose through GLUT1 (and possibly via
astrocytes and gap junctions; CX, connexin) for glycolysis. Pyruvate is metabolised in
mitochondria (yellow) for ATP generation (TCA, tricarboxylic acid cycle). With the onset
of myelination (‘developmental switch’), glucose also serves the synthesis of fatty acid
(FAS) and myelin lipids from acetyl-CoA. In post-myelination oligodendrocytes, glycolysis
can yield sufficient ATP to support oligodendrocyte survival. Glycolysis products are used
by myelinated axons when energy levels are low6,21. Lactate (or pyruvate when NADH is
oxidized in oligodendroglial mitochondria) can be directly transferred via monocarboxylic
acid transporters (MCT1, MCT2), which reside in internodal myelin24 and the axonal
compartment, such that lactate is rapidly cleared in vivo (in c). Note that myelinated axons,
largely shielded from the extracellular milieu4, are separated by a thin periaxonal space from
the oligodendroglial cytoplasm filling the inner loops of myelin (‘cytosolic channel’) and
paranodal loops.
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